Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Free Cash Flow: 2016-2024

Historic Free Cash Flow for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $4.2 million.

  • Organogenesis Holdings' Free Cash Flow fell 86.22% to $844,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.7 million, marking a year-over-year decrease of 1427.81%. This contributed to the annual value of $4.2 million for FY2024, which is 36.27% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Free Cash Flow of $4.2 million as of FY2024, which was down 36.27% from $6.6 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Free Cash Flow ranged from a high of $30.8 million in FY2021 and a low of -$12.2 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Free Cash Flow had a median value of $4.2 million in 2024 and averaged $563,333.
  • As far as peak fluctuations go, Organogenesis Holdings' Free Cash Flow soared by 351.87% in 2021, and later tumbled by 129.39% in 2022.
  • Organogenesis Holdings' Free Cash Flow (Yearly) stood at -$12.2 million in 2020, then soared by 351.87% to $30.8 million in 2021, then crashed by 129.39% to -$9.0 million in 2022, then spiked by 172.50% to $6.6 million in 2023, then slumped by 36.27% to $4.2 million in 2024.